Late-Onset Proteinuria After Antithymocyte Globulin Induction and De Novo Sirolimus Monotherapy in Kidney Transplant Recipients

被引：2
|
作者：
Thomusch, Oliver [1 ]
Tittelbach-Helmrich, Dietlind [1 ]
Seifert, Gabriel [1 ]
Pisarski, Przemyslaw [1 ]
机构：
[1] Univ Freiburg, Dept Gen & Visceral Surg, D-79106 Freiburg, Germany
来源：
TRANSPLANTATION | 2011年 / 92卷 / 11期
关键词：
IMMUNOSUPPRESSION; CAMPATH-1H;
D O I：
10.1097/TP.0b013e3182366423
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E62 / E63
页数：2
相关论文
共 50 条
  • [31] Late-Onset De Novo Minimal Change Disease Presenting With Nephrotic Range Proteinuria More Than 1 Year After Combined Heart-Kidney Transplant: A Case Report
    Hussain, Zoya
    Chhabra, Darshika
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (09) : 3099 - 3102
  • [32] Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus
    Devresse, Arnaud
    Leruez-Ville, Marianne
    Scemla, Anne
    Avettand-Fenoel, Veronique
    Morin, Lise
    Lebreton, Xavier
    Tinel, Claire
    Amrouche, Lucile
    Lamhaut, Lionel
    Timsit, Marc Olivier
    Zuber, Julien
    Legendre, Christophe
    Anglicheau, Dany
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (02)
  • [33] Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients
    Bruminhent, Jackrapong
    Worawichawong, Suchin
    Tongsook, Chutatip
    Pasomsub, Ekawat
    Boongird, Sarinya
    Watcharananan, Siriorn P.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (12):
  • [34] Advagraf® with or without an induction therapy for de novo kidney-transplant recipients
    Noble, Johan
    Jouve, Thomas
    Rostaing, Lionel
    Malvezzi, Paolo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (06) : 461 - 467
  • [35] Comparison of Renal Outcomes for Liver Transplant Recipients With Pretransplant Renal Dysfunction Receiving Sirolimus Or Tacrolimus With Rabbit Antithymocyte Globulin Induction
    Duhart, B.
    Ally, W.
    Rao, V.
    Krauss, A.
    Eason, J.
    Vanatta, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [36] Combined Antithymocyte Globulin (ATG) and Rituximab (RTX) Induction in African American (AA) Kidney Transplant Recipients.
    Patel, S. J.
    Kuten, S.
    Pham, C.
    Knight, R.
    Hobeika, M.
    Nguyen, D.
    Graviss, E.
    Yi, S.
    Eagar, T.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 819 - 820
  • [37] Basiliximab vs Antithymocyte Globulin Induction with Early Steroid Withdrawal in Kidney Transplant Recipients: Early Rejection Outcomes
    Szczepanik, A.
    Burrelli, C.
    Bixby, A.
    Yadav, K.
    Chavin, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 908 - 909
  • [38] Serum Sickness After Treatment With Rabbit Antithymocyte Globulin in Kidney Transplant Recipients With Previous Rabbit Exposure
    Boothpur, Raghavender
    Hardinger, Karen L.
    Skelton, Rebecca M.
    Lluka, Brunilda
    Koch, Matthew J.
    Miller, Brent W.
    Desai, Niraj M.
    Brennan, Daniel C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (01) : 141 - 143
  • [39] No detectable indirect effects of late-onset Cytomegalovirus disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
    Lamoth, Frederic
    Manuel, Criol
    Meylan, Pascal R.
    Venetz, Jean-Pierre
    Faouzi, Mohammed
    Pascual, Manuel
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : S13 - S13
  • [40] LATE-ONSET PNEUMONOCYSTIS JIROVECI IN KIDNEY TRANSPLANT RECIPIENTS. A SINGLE CENTER EXPERIENCE
    Melexopoulou, Christina
    Marinaki, Smaragdi
    Vallianou, Kalliopi
    Drouzas, Konstantinos
    Pavlopoulou, Ioanna
    Lambrou, Panagiota
    Boletis, John
    TRANSPLANT INTERNATIONAL, 2019, 32 : 166 - 167
12345